Michael F Maclean - Net Worth and Insider Trading
Michael F Maclean Net Worth
The estimated net worth of Michael F Maclean is at least $4 Million dollars as of 2024-05-12. Michael F Maclean is the SVP, Chief Accounting Officer of Biogen Inc and owns about 11,634 shares of Biogen Inc (BIIB) stock worth over $3 Million. Michael F Maclean is also the CFO of Avidity Biosciences Inc and owns about 44,093 shares of Avidity Biosciences Inc (RNA) stock worth over $1 Million. Details can be seen in Michael F Maclean's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael F Maclean has not made any transactions after 2024-03-13 and currently still holds the listed stock(s).
Transaction Summary of Michael F Maclean
Michael F Maclean Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael F Maclean owns 4 companies in total, including Avidity Biosciences Inc (RNA) , Akcea Therapeutics Inc (AKCA) , and Biogen Inc (BIIB) among others .
Click here to see the complete history of Michael F Maclean’s form 4 insider trades.
Insider Ownership Summary of Michael F Maclean
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RNA | Avidity Biosciences Inc | 2024-03-13 | Chief Financial Officer |
AKCA | Akcea Therapeutics Inc | 2020-01-15 | Chief Financial Officer |
BIIB | Biogen Inc | 2010-08-02 | SVP & Chief Accounting Officer |
2021-06-16 | director |
Michael F Maclean Latest Holdings Summary
Michael F Maclean currently owns a total of 2 stocks. Among these stocks, Michael F Maclean owns 11,634 shares of Biogen Inc (BIIB) as of August 2, 2010, with a value of $3 Million and a weighting of 69.24%. Michael F Maclean also owns 44,093 shares of Avidity Biosciences Inc (RNA) as of March 13, 2024, with a value of $1 Million and a weighting of 30.76%.
Latest Holdings of Michael F Maclean
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BIIB | Biogen Inc | 2010-08-02 | 11,634 | 221.50 | 2,576,931 |
RNA | Avidity Biosciences Inc | 2024-03-13 | 44,093 | 25.96 | 1,144,654 |
Holding Weightings of Michael F Maclean
Michael F Maclean Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael F Maclean has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 9,542 shares on August 2, 2010, which brought Michael F Maclean around $542,463.
According to the SEC Form 4 filings, Michael F Maclean has made a total of 2 transactions in Avidity Biosciences Inc (RNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Avidity Biosciences Inc is the sale of 40,000 shares on March 13, 2024, which brought Michael F Maclean around $980,800.
Insider Trading History of Michael F Maclean
- 1
Michael F Maclean Trading Performance
Michael F Maclean Ownership Network
Ownership Network List of Michael F Maclean
Ownership Network Relation of Michael F Maclean
Michael F Maclean Owned Company Details
What does Avidity Biosciences Inc do?
Who are the key executives at Avidity Biosciences Inc?
Michael F Maclean is the Chief Financial Officer of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include director & President and CEO Sarah Boyce , Chief Scientific Officer Arthur A Levin , and Chief Human Resources Officer Teresa Mccarthy .
Avidity Biosciences Inc (RNA) Insider Trades Summary
Over the past 18 months, Michael F Maclean made 2 insider transaction in Avidity Biosciences Inc (RNA) with a net sale of 41,616. Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 119,600 shares made by Arthur A Levin , a net sale of 223,092 shares made by Sarah Boyce , and a net sale of 4,129 shares made by W. Michael Flanagan .
In summary, during the past 3 months, insiders sold 265,641 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 265,641 shares. During the past 18 months, 390,502 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 390,502 shares.
Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avidity Biosciences Inc Insider Transactions
Michael F Maclean Mailing Address
Above is the net worth, insider trading, and ownership report for Michael F Maclean. You might contact Michael F Maclean via mailing address: 14 Cambridge Center, Cambridge Ma 02142.